Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
Ciccia F, Guggino G, Rizzo A, Alessandro R, Carubbi F, Giardina A, Cipriani P, Ferrante A, Cannizzaro A, Giacomelli R, Triolo G.
Ciccia F, et al. Among authors: ferrante a.
Rheumatology (Oxford). 2014 Jul;53(7):1313-20. doi: 10.1093/rheumatology/keu004. Epub 2014 Mar 6.
Rheumatology (Oxford). 2014.
PMID: 24602921
Free article.